Propanc Biopharma's total assets for Q2 2025 were $78.53K, an increase of 23.39% from the previous quarter. PPCBD total liabilities were $4.24M for the fiscal quarter, a 1.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.